Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata is a common autoimmune disease affecting about 2% of people, causing significant disability and often associated with mental health issues and other autoimmune conditions.

Lymphocytes, especially CD8+ T cells, play a key role in causing alopecia areata, and targeting them may lead to new treatments.

Hormones like androgens, estrogen, thyroid hormones, and stress hormones can contribute to hair loss, and treatments target these hormonal imbalances.

New treatments for Alopecia Areata show promise but need to be more effective and affordable.

The review found that different stem cell types in the skin are crucial for repair and could help treat skin diseases and cancer.

Alopecia areata can be triggered by specific immune cells without genetic or environmental factors.

Enzymes called PADIs play a key role in hair growth and loss.

Four natural compounds were found to promote hair growth effectively.

Certain daily habits like stress, diet, and sleep can affect the severity of hair loss in alopecia areata.

Hair loss from Alopecia Areata is caused by both genes and environment, with several treatments available but challenges in cost and relapse remain.

A new treatment using nanoparticles can effectively prevent and reduce hair loss caused by chemotherapy.

The combination of oral PUVA and corticosteroids helps regrow hair in severe alopecia areata.

Melanoma development can be linked to the breakdown of skin's melanin-producing units.

Alopecia areata can be reversed by JAK inhibitors, promoting hair regrowth.

Current treatments for Alopecia Areata have mixed success, and there's a need for better, more accessible options and support for affected individuals.

New targeted immunotherapies are improving treatment for inflammatory skin diseases.

More research is needed to understand the genetic causes of Alopecia areata to develop better treatments.

New treatments for alopecia areata show promise, but more research is needed to confirm their effectiveness.

Topical immunotherapy can treat alopecia areata, but its effectiveness varies and the exact mechanism is unclear.

NKG2D+CD4+ T cells are higher in alopecia areata patients and may be involved in the disease.

JAK inhibitors help hair regrowth but not fully effective for androgenetic alopecia.

Estrogen and androgenic hair increase melanoma risk, especially in European-ancestry individuals.

Topical drugs and near-infrared light therapy show potential for treating alopecia.

Erdr1 could be a new marker for diagnosing hair loss.

Hair color is influenced by genetics and can indicate certain health conditions.

The Lexington LaserComb helped regrow hair in mice with a condition similar to human hair loss.

All three shampoos reduced dandruff and hair loss, but ketoconazole and piroctone olamine also made hair thicker.

Special and immunohistochemical stains are not routinely needed for diagnosing hair disorders.

Gray hair can potentially be reversed, leading to new treatments.

Ritlecitinib effectively improves hair growth in alopecia areata patients, regardless of hair loss pattern.